| scholarly article | Q13442814 |
| P50 | author | José Luis López-Campos Bodineau | Q64854590 |
| Joan B. Soriano | Q42305955 | ||
| P2093 | author name string | Wan Tan | |
| P2860 | cites work | Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 |
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 | ||
| Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors | Q23910813 | ||
| Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey | Q23912729 | ||
| Chronic obstructive pulmonary disease prevalence among nonsmokers by occupation in the United States | Q23916248 | ||
| Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010 | Q23922840 | ||
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q26782024 | ||
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q28111913 | ||
| Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 | ||
| Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach | Q28391485 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 | ||
| International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study | Q29614971 | ||
| The burden of disease in older people and implications for health policy and practice | Q30205749 | ||
| Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. | Q44539984 | ||
| Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions | Q44608605 | ||
| COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women | Q44624536 | ||
| The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice | Q45227007 | ||
| Economic burden of chronic obstructive pulmonary disease. | Q45388291 | ||
| Agricultural exposures and chronic bronchitis: findings from the AGRICAN (AGRIculture and CANcer) cohort | Q46701635 | ||
| Are the Diagnostic Criteria for Asthma-COPD Overlap Syndrome Appropriate in Biomass Smoke-Induced chronic obstructive pulmonary disease? | Q46755239 | ||
| Respiratory Symptoms in Indian Women Using Domestic Cooking Fuels | Q47315049 | ||
| Economic analysis of the Confronting COPD survey: an overview of results | Q48023793 | ||
| Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. | Q49160102 | ||
| Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis. | Q51000570 | ||
| Twenty-five year trends in prevalence of chronic bronchitis and the trends in relation to smoking. | Q51115254 | ||
| Chronic obstructive pulmonary disease in the awareness of Polish society. Report from the public opinion survey by the Polish Respiratory Society and TNS Polska. | Q51667864 | ||
| Smoking and lung function of Lung Health Study participants after 11 years. | Q51705571 | ||
| Potential misclassification of causes of death from COPD. | Q51797977 | ||
| Exacerbations of chronic obstructive pulmonary disease. | Q53175930 | ||
| A clinical study of COPD severity assessment by primary care physicians and their patients compared with spirometry. | Q53240289 | ||
| Global Burden of Disease 2005: call for collaborators | Q53680400 | ||
| Conocimientos de la población general sobre la enfermedad pulmonar obstructiva crónica y sus determinantes: situación actual y cambios recientes | Q57777959 | ||
| The diagnostic accuracies of chronic obstructive pulmonary disease (COPD) in general practice: The results of the MAGIC (Manchester Airways Group Identifying COPD) study | Q80272843 | ||
| External validation of a COPD diagnostic questionnaire | Q81497654 | ||
| Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe | Q83491506 | ||
| Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health intervention | Q85910850 | ||
| Effect of a chronic obstructive pulmonary disease (COPD) intervention on COPD awareness in a regional city in Japan | Q86873826 | ||
| Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study | Q34240886 | ||
| Detection of airflow limitation using a handheld spirometer in a primary care setting | Q34503139 | ||
| Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea | Q35103337 | ||
| Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study | Q35131432 | ||
| Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey. | Q35152641 | ||
| COPD Diagnostic Questionnaire (CDQ) for selecting at-risk patients for spirometry: a cross-sectional study in Australian general practice | Q35216195 | ||
| Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study | Q35798055 | ||
| Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study | Q35798096 | ||
| Economic Burden of COPD in the Presence of Comorbidities. | Q35825585 | ||
| Present and future costs of COPD in Iceland and Norway: results from the BOLD study | Q35906562 | ||
| Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study | Q36487800 | ||
| Evaluation of interventions to reduce air pollution from biomass smoke on mortality in Launceston, Australia: retrospective analysis of daily mortality, 1994-2007. | Q36522136 | ||
| Measuring the global burden of disease and epidemiological transitions: 2002-2030. | Q36561190 | ||
| Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). | Q36725219 | ||
| Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature | Q36760100 | ||
| Global burden of COPD: risk factors, prevalence, and future trends | Q36926621 | ||
| Marijuana and chronic obstructive lung disease: a population-based study | Q37151305 | ||
| An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease | Q37783859 | ||
| Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation | Q37911779 | ||
| Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea | Q38218069 | ||
| Risk factors and early origins of chronic obstructive pulmonary disease | Q38239928 | ||
| The global burden of chronic respiratory disease in adults | Q38292303 | ||
| Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries | Q38355133 | ||
| Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis | Q38422566 | ||
| Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. | Q38860439 | ||
| A comprehensive, national survey of spirometry in Spain: current bottlenecks and future directions in primary and secondary care | Q39467012 | ||
| Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study | Q39737579 | ||
| Chronic respiratory symptoms, spirometry and knowledge of COPD among general population | Q39752489 | ||
| Prevalence of heavy smoking in California and the United States, 1965-2007. | Q39771563 | ||
| COPD prevalence and its association with occupational exposures in a general population | Q39917024 | ||
| Chronic obstructive pulmonary disease: current burden and future projections. | Q40353633 | ||
| Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease | Q41231716 | ||
| ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers. | Q41537467 | ||
| Variability of hospital resources for acute care of COPD patients: the European COPD Audit | Q43943798 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 14-23 | |
| P577 | publication date | 2015-10-23 | |
| P1433 | published in | Respirology | Q15753093 |
| P1476 | title | Global burden of COPD | |
| P478 | volume | 21 |
| Q40060849 | A Multicenter RCT of Zephyr® Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM). |
| Q93136143 | A qualitative study of chronic obstructive pulmonary disease patient perceptions of the barriers and facilitators to adopting digital health technology |
| Q57809552 | Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) |
| Q99726312 | Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece |
| Q59240847 | Administrative databases and clinical governance: The case of COPD |
| Q93145813 | Alpha-1 Antitrypsin Replacement in Patients With COPD |
| Q64289874 | An accurate prediction model to identify undiagnosed at-risk patients with COPD: a cross-sectional case-finding study |
| Q55514034 | An attempt at modeling COPD epidemiological trends in France. |
| Q92105320 | Analyze and Identify Peiminine Target EGFR Improve Lung Function and Alleviate Pulmonary Fibrosis to Prevent Exacerbation of Chronic Obstructive Pulmonary Disease by Phosphoproteomics Analysis |
| Q90132747 | Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance |
| Q36223649 | Application of Mixed Effects Limits of Agreement in the Presence of Multiple Sources of Variability: Exemplar from the Comparison of Several Devices to Measure Respiratory Rate in COPD Patients |
| Q57044351 | Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism |
| Q91647707 | Associations of Ambient Air Pollutant Concentrations With Respiratory Symptoms and Perceived Health Status in Japanese Adults With and Without Chronic Respiratory Diseases: A Panel Study |
| Q61798968 | BAMBI regulates macrophages inducing the differentiation of Treg through the TGF-β pathway in chronic obstructive pulmonary disease |
| Q91686040 | Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial |
| Q89795816 | Bronchoscopic lung volume reduction with endobronchial valves for heterogeneous emphysema: long-term results |
| Q49618500 | Burden of COPD in Nepal. |
| Q92533368 | CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition |
| Q47551395 | COPD Patients as Vulnerable Subpopulation for Exposure to Ambient Air Pollution |
| Q90010599 | COPD-Specific Self-Management Support Provided by Trained Educators in Everyday Practice is Associated with Improved Quality of Life, Health-Directed Behaviors, and Skill and Technique Acquisition: A Convergent Embedded Mixed-Methods Study |
| Q44622430 | COPD: Lessons learned, forging a fantastic future |
| Q46301271 | Cause-specific mortality for 249 causes in Brazil and states during 1990-2015: a systematic analysis for the global burden of disease study 2015. |
| Q92290085 | Characteristics of factors for decreased lung function in elderly patients with type 2 diabetes |
| Q47706055 | Chronic respiratory disease: an unrecognized risk factor in dialysis |
| Q58576172 | Circulating serotonin levels in COPD patients: a pilot study |
| Q89566463 | Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study |
| Q92356180 | Clinical characteristics and economic burden of tuberculous-destroyed lung in Korea: a National Health Insurance Service-National Sample Cohort-based study |
| Q47122143 | Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study. |
| Q37603579 | Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis |
| Q55020515 | Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective. |
| Q64083586 | Curcumin and Curcumol Inhibit NF-B and TGF-/Smads Signaling Pathways in CSE-Treated RAW246.7 Cells |
| Q33697687 | Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study |
| Q58699171 | Diagnosis-related differences in the quality of end-of-life care: A comparison between cancer and non-cancer patients |
| Q64124751 | Difference in Long-Term Trends in COPD Mortality between China and the U.S., 1992⁻2017: An Age⁻Period⁻Cohort Analysis |
| Q47109199 | Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity |
| Q59812618 | Digitalizing multidisciplinary pulmonary rehabilitation in COPD with a smartphone application: an international observational pilot study |
| Q61453764 | Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam |
| Q55384969 | Dysregulated Functions of Lung Macrophage Populations in COPD. |
| Q64079595 | Effectiveness and Safety of Oral on Stable COPD of GOLD Stages 2-3: Systematic Review and Meta-Analysis |
| Q89883412 | Effects of Ambient Temperature on Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Results from a Time-Series Analysis of 143318 Hospitalizations |
| Q59796537 | Effects of a COPD self-management support intervention: a randomized controlled trial |
| Q91773783 | Effects of use of an eHealth platform e-Vita for COPD patients on disease specific quality of life domains |
| Q37661569 | Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial |
| Q57482978 | Enlightening chronic obstructive pulmonary disease through patients' and caregivers' narratives |
| Q28078352 | Extracellular Vesicles in Chronic Obstructive Pulmonary Disease |
| Q94400314 | Factors influencing referral to and uptake and attendance of pulmonary rehabilitation for chronic obstructive pulmonary disease: a qualitative evidence synthesis of the experiences of service users, their families, and healthcare providers |
| Q28070419 | Genetic Polymorphism of Angiotensin-Converting Enzyme and Chronic Obstructive Pulmonary Disease Risk: An Updated Meta-Analysis |
| Q36229721 | Genetic polymorphism of heme oxygenase 1 promoter in the occurrence and severity of chronic obstructive pulmonary disease: a meta-analysis |
| Q38700796 | Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice |
| Q94355622 | Head‐to‐head oral prophylactic antibiotics therapy for chronic obstructive pulmonary disease |
| Q46670795 | Healthy lifestyle behaviors among individuals with chronic obstructive pulmonary disease in urban and rural communities in China: a large community-based epidemiological study |
| Q33588100 | Heterozygous Vangl2Looptail mice reveal novel roles for the planar cell polarity pathway in adult lung homeostasis and repair |
| Q55237152 | Hospitalization Trends in Adult Patients with COPD and Other Respiratory Diseases in Northeast China from 2005 to 2015. |
| Q45181342 | Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial. |
| Q91789123 | Improving Influenza Vaccination Coverage Among Patients With COPD: A Pilot Project |
| Q47127219 | Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population |
| Q37603590 | Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study |
| Q53697380 | Inflammatory and Metabolic Responses to Different Resistance Training on Chronic Obstructive Pulmonary Disease: A Randomized Control Trial. |
| Q40235118 | Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease |
| Q59135278 | Interventions to increase referral and uptake to pulmonary rehabilitation in people with COPD: a systematic review |
| Q91705446 | Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients |
| Q99565824 | Lung cancer and obstructive lung disease in never smokers |
| Q93060298 | Lyn regulates epithelial-mesenchymal transition in CS-exposed model through Smad2/3 signaling |
| Q89910340 | MIP-T3 Expression Associated with Defects of Ciliogenesis in Airway of COPD Patients |
| Q37509985 | Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis. |
| Q46460982 | Master Autophagy Regulator Transcription Factor EB Regulates Cigarette Smoke-Induced Autophagy Impairment and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis |
| Q30235126 | Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives. |
| Q90691780 | MicroRNA-186 is associated with hypoxia-inducible factor-1α expression in chronic obstructive pulmonary disease |
| Q89883405 | Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD |
| Q61447519 | Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study |
| Q92822414 | Nasal Delivery of a Commensal Pasteurellaceae Species Inhibits Nontypeable Haemophilus influenzae Colonization and Delays Onset of Otitis Media in Mice |
| Q92862036 | Nasal high flow: physiology, efficacy and safety in the acute care setting, a narrative review |
| Q93023067 | National retrospective cohort study to identify age-specific fatality risks of comorbidities among hospitalised patients with influenza-like illness in Taiwan |
| Q47309369 | Oxygen saturation measurements in telemonitoring of patients with COPD: a systematic review |
| Q55360310 | Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol. |
| Q89566581 | Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study |
| Q38733970 | Peripheral muscle training in patients with chronic obstructive pulmonary disease: novel approaches and recent advances. |
| Q90467049 | Peroxisome Proliferator-Activated Receptor (PPARγ) Plays a Protective Role in Cigarette Smoking-Induced Inflammation via AMP-Activated Protein Kinase (AMPK) Signaling |
| Q89566471 | Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study |
| Q57616535 | Prescription and use of inhaled medication in patients with asthma and COPD: Baseline-data of an adherence-Intervention-study |
| Q49800955 | Prevalence of chronic obstructive pulmonary disease (COPD) in China in 1990 and 2010. |
| Q53070137 | Prevalence of osteoarthritis in individuals with COPD: a systematic review. |
| Q58760591 | Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β-Agonist Therapy: An Integrated Post Hoc Analysis |
| Q55229524 | Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort. |
| Q37623974 | Risk factors for FEV1 decline in mild COPD and high-risk populations |
| Q47665614 | Role of BMI, airflow obstruction, St George's Respiratory Questionnaire and age index in prognostication of Asian COPD. |
| Q37691618 | Seasonal variability in clinical care of COPD outpatients: results from the Andalusian COPD audit. |
| Q93150096 | Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial |
| Q87885761 | Short-term effects of ambient fine particulate matter pollution on hospital visits for chronic obstructive pulmonary disease in Beijing, China |
| Q47664739 | Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease. |
| Q55223776 | Symptomatic burden of COPD for patients receiving dual or triple therapy. |
| Q38793754 | Telehealthcare for patients suffering from chronic obstructive pulmonary disease: effects on health-related quality of life: results from the Danish 'TeleCare North' cluster-randomised trial |
| Q94401039 | Telehealthcare for remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD) |
| Q89698816 | The Geographical Distribution of Morbidity Caused By Chronic Obstructive Pulmonary Disease in Turkey: Copd Turkey-2 |
| Q64982726 | The Role of Revefenacin in Chronic Obstructive Pulmonary Disease. |
| Q57810494 | The Vagus Nerve Can Predict and Possibly Modulate Non-Communicable Chronic Diseases: Introducing a Neuroimmunological Paradigm to Public Health |
| Q37412962 | The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study |
| Q90712293 | The burden of chronic obstructive pulmonary disease in open heart surgery-a retrospective cohort analysis of postoperative complications: STROBE compliant |
| Q49641447 | The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease. |
| Q64066111 | The cullin4A is up-regulated in chronic obstructive pulmonary disease patient and contributes to epithelial-mesenchymal transition in small airway epithelium |
| Q93377739 | The dose of inhaled corticosteroids in patients with COPD: when less is better |
| Q92759852 | The effect of Tualang honey on the quality of life of patients with chronic obstructive pulmonary disease: A randomized controlled trial |
| Q58574367 | The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models |
| Q47147311 | The effectiveness of a nurse-led illness perception intervention in COPD patients: a cluster randomised trial in primary care |
| Q91772616 | The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study |
| Q64101434 | The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects |
| Q91950145 | The rat model of COPD skeletal muscle dysfunction induced by progressive cigarette smoke exposure: a pilot study |
| Q40748398 | The role of air pollution in COPD and implications for therapy |
| Q92173324 | The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study |
| Q55257340 | The unmet global burden of COPD. |
| Q64081400 | To live a life with COPD - the consequences of symptom burden |
| Q60928796 | Traditional Chinese medicine classic herbal formula Xiaoqinglong decoction for acute exacerbation of chronic obstructive pulmonary disease: A systematic review protocol |
| Q60928816 | Traditional Chinese medicine tonifying kidney therapy (Bu shen) for stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis |
| Q47104855 | Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. |
| Q47654420 | Understanding of COPD among final-year medical students. |
| Q39267369 | Up-Regulation of Claudin-6 in the Distal Lung Impacts Secondhand Smoke-Induced Inflammation |
| Q92368097 | Utility of FEV1/FEV6 index in patients with multimorbidity hospitalized for decompensation of chronic diseases |
| Q92747279 | Wearable Finger Pulse Oximetry for Continuous Oxygen Saturation Measurements During Daily Home Routines of Patients With Chronic Obstructive Pulmonary Disease (COPD) Over One Week: Observational Study |
| Q96018260 | Whole transcriptome analyis of human lung tissue to identify COPD-associated genes |
| Q39216404 | Year in review 2016: Chronic obstructive pulmonary disease and asthma |
| Q57169668 | gene polymorphism is associated with COPD and COPD with pulmonary hypertension: a meta-analysis |
Search more.